€25.85
0.86% yesterday
L&S, Jul 05, 10:55 pm CET
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Pfizer Stock price

$28.05
-1.50 5.08% 1M
-1.42 4.82% 6M
-0.74 2.57% YTD
-8.41 23.07% 1Y
-11.68 29.40% 3Y
-13.56 32.58% 5Y
-0.83 2.88% 10Y
NYSE, Closing price Fri, Jul 05 2024
+0.35 1.26%
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Key metrics

Market capitalization $158.95b
Enterprise Value $216.83b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 42.47
EV/Sales (TTM) EV/Sales 3.94
P/S ratio (TTM) P/S ratio 2.89
P/B ratio (TTM) P/B ratio 1.72
Dividend yield 5.88%
Last dividend (FY23) $1.65
Revenue growth (TTM) Revenue growth -40.73%
Revenue (TTM) Revenue $55.09b
EBIT (operating result TTM) EBIT $1.78b
Free Cash Flow (TTM) Free Cash Flow $5.11b
Cash position $11.93b
EPS (TTM) EPS $-0.06
P/E forward 16.91
P/S forward 2.63
EV/Sales forward 3.58
Short interest 1.10%
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Pfizer forecast:

9x Buy
35%
17x Hold
65%

Analyst Opinions

26 Analysts have issued a Pfizer forecast:

Buy
35%
Hold
65%

Financial data from Pfizer

Mar '24
+/-
%
Net Profit -289 -289
101% 101%
-1%
Depreciation and Amortization 6,539 6,539
22% 22%
12%
Stock Compensation 640 640
28% 28%
1%
Operating Cash Flow 8,578 8,578
69% 69%
16%
Investments 3,472 3,472
7% 7%
6%
Dividend Paid 9,316 9,316
3% 3%
17%
Free Cash Flow 5,106 5,106
79% 79%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Positive
The Motley Fool
about 8 hours ago
Pfizer's been raising its dividend payout for 15 years, and a heap of new products could help it continue the streak. The largest publicly traded business development company, Ares Capital offers investors a yield above 9% at recent prices.
Positive
MarketBeat
one day ago
Despite their recent struggles, these three industry giants hold the promise of significant upside. With favorable consensus price targets and ratings, attractive P/E valuations, solid earnings growth projections, and some highly attractive dividend yields, they present a hopeful picture for income and value-oriented investors.
Positive
24/7 Wall Street
one day ago
24/7 Insights Wounded blue chip stocks can offer huge total return potential.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 88,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today